Australia
First patient treated in Clarity's therapeutic prostate cancer trial
Highlights * Clarity Pharmaceuticals recruits and treats its first patient in the therapeutic phase of its SAR-bisPSMA theranostic clinical trial SECuRE (NCT04868604)[1] investigating Targeted Copper Theranostics (TCTs) in patients with metastatic castrate-resistant prostate cancer (mCRPC) ...
Global Milk Industry Digestibility Breakthrough
--World-first Haelen technology achieves 100% fresh, natural milk that is twice as digestible BRISBANE, Australia, Oct. 4, 2022 /PRNewswire/ -- Naturo, the company behind the world-first patented 'Haelen' milk processing technology which gives fresh milk a 60-day shelf life has achieved another ...
DetectedX to Provide Free Access to Radiology Online Learning Platform to Radiology Across Borders to Enhance Global Charity's Teaching Initiatives
Radiology Across Borders will Promote Access to DetectedX's On-Demand, Web-Based Educational Platform to Clinicians from Developing Nations to Improve Diagnostic Accuracy SYDNEY, Oct. 3, 2022 /PRNewswire/ -- DetectedX announced today that it will provide free access to its Radiology Online Learn...
Envato reveals significant growth in demand for its unlimited subscription service, as Envato Elements grows to become a market leader
MELBOURNE, Australia, Sept. 29, 2022 /PRNewswire/ -- Envato has revealed a 23%
jump in subscribers on itsElements
JXSN#4 FLOWS HELIUM (6.5% He) TO SURFACE GALACTICA/PEGASUS
Highlights * JXSN#4 exploration well completed in Blue Star's Galactica/Pegasus prospect. * Analysis of gas obtained during drilling shows a calculated air-free gas composition of 6.5% helium in theLyons formation. * Both the upper and lower Lyons sands are gas charged with helium. * JXSN#4...
CONTINGENT RESOURCE CERTIFIED FOR VOYAGER FIELD
Highlights * 2C net unrisked contingent helium resource of 643 MMscf for Voyager (100% BNL). * High side (3C) net unrisked estimate of 1,228 MMscf. * First declaration of contingent resource at Voyager is in addition to existing prospective resources at Galactica/Pegasus, Enterprise, Argo, ...
New report offers blueprint for regulation of facial recognition technology
SYDNEY, Sept. 26, 2022 /PRNewswire/ -- A new report
Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson's Disease and Movement Disorders
- Wearable sensors strongly correlated with clinical scales on motor impairment - - bioMUSE Study Validates Use of Wearable Sensors for Alterity's Ongoing Phase 2 Clinical Trial - MELBOURNE, Australia and SAN FRANCISCO, Sept. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATH...
Capitalise.ai and Pepperstone announce strategic partnership to enhance trading experience
Pepperstone will offer their traders an innovative AI-driven auto-trading experience Pepperstone, an award-winning CFD & Forex broker has teamed up with Capitalise.ai to offer their traders a seamless, auto-trading experience. This new partnership enables Pepperstone clients to easily analyze, a...
Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy
Regulatory Authorization Granted to Proceed with ATH434 Phase 2 Clinical Trial MELBOURNE, Australia and SAN FRANCISCO, Sept. 20, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying tr...
MD ANDERSON AND RADIOPHARM THERANOSTICS LAUNCH JOINT VENTURE TO DEVELOP NOVEL RADIOPHARMACEUTICALS
MELBOURNE, Australia, Sept. 13, 2022 /PRNewswire/ -- The University of Texas MD
Anderson Cancer Center
LiveHire and Raise Recruiting Clients Wow Direct Sourcing Space
MIAMI, Sept. 12, 2022 /PRNewswire/ -- LiveHire
LIVEHIRE AND HIREGENICS LAUNCH 3 NEW DIRECT SOURCING PROGRAMS TO PREMIER FORTUNE 500 COMPANIES
MIAMI, Sept. 8, 2022 /PRNewswire/ -- LiveHire
BAI's Group CEO to speak at TMT M&A Forum USA 2022
SYDNEY, Sept. 8, 2022 /PRNewswire/ -- BAI Communications
New Fortune 1000 Direct Sourcing Clients for LiveHire and Partner Broadleaf
MIAMI , Sept. 7, 2022 /PRNewswire/ -- LiveHire
Recruitment opens for Phase II trial in prostate cancer with Cu-64 SAR-Bombesin in the US
SYDNEY, Sept. 5, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that the US-based diagn...
LiveHire Announces Launch of "Thrive" Global Partner Ecosystem to Bring Together World Class Technologies and Service Providers
MIAMI, Aug. 30, 2022 /PRNewswire/ -- LiveHire Ltd. (ASX:LVH), a global software-as-a-service (SaaS) platform connecting companies and candidates, today announced the launch of the global Thrive Partner Network, bringing together the best technologies and service providers to deliver total talent ...
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe
Second region now open for enrolment for rare, rapidly progressive, neurodegenerative disease MELBOURNE, Australia and SAN FRANCISCO, Aug. 25, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing diseas...
LiveHire and CrintellTech Announce Strategic Integration to Automate Candidate Sourcing and Streamline the Recruiting Life-Cycle
MIAMI and CHEYENNE, Wyo., Aug. 23, 2022 /PR Newswire/ -- LiveHire Ltd. (ASX: LVH), a global software-as-a-service (SaaS)Total Talent Acquisition platform that helps companies connect with and hire the talent they need, and CrintellTech, an AI-driven recruitment intelligence platform that automate...
Clarity advances to cohort 3 of the CL04 trial of SARTATE™ in paediatric neuroblastoma
Highlights * Cohort 2 completed in participants with neuroblastoma who received therapy with67Cu SARTATE™ at a dose of 175MBq/kg body weight * No Dose Limiting Toxicities (DLTs) have been reported in cohort 1 and cohort 2 * Safety Review Committee (SRC) has recommended the trial continues w...
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00